Developing RNAi therapeutics for the treatment of rare liver disease and cancer.
Industry: Health Care
First Day Return: +206.7%
Industry: Health Care
IPO Data | |
---|---|
IPO File Date | 12/31/2013 |
Offer Price | $15.00 |
Price Range $14.00 - $14.00 | |
Offer Shares (mm) | 6.0 |
Deal Size ($mm) | $90 |
Lock-Up Date | IPO Pro Only |
Street Research | IPO Pro Only |
IPO Data | |
---|---|
IPO Date | 01/29/2014 |
Offer Price | IPO Intelligence Only |
Price Range | IPO Intelligence Only |
Offer Shares (mm) | IPO Intelligence Only |
Deal Size ($mm) | $90 |
Lock-Up Date | IPO Intelligence Only |
Street Research | IPO Intelligence Only |
Underwriters |
---|
IPO Intelligence Only |
Company Data | |
---|---|
Headquarters | Watertown, MA, United States |
Founded | 2006 |
Employees at IPO | 24 |
Website www.dicerna.com |